Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane

Area of Science:

• Muscle physiology and disease
• Sarcolemma repair mechanisms
• Calcium signaling in skeletal muscle

Background:

• Dysferlinopathies, like limb girdle muscular dystrophy 2B and Miyoshi myopathy, stem from mutations in the DYSF gene.
• Dysferlin's known role in sarcolemma repair, with emerging evidence linking it to transverse (t-) tubule calcium (Ca2+) signaling.

Purpose of the Study:

• To investigate the role of dysferlin in the t-tubule membrane of skeletal muscle fibers.
• To explore the impact of dysferlin deficiency on t-tubule integrity and Ca2+ signaling under stress.
• To assess the therapeutic potential of modulating Ca2+ signaling in dysferlinopathies.

Main Methods:

• Localization of dysferlin in mature skeletal muscle fiber t-tubules.
• In vitro experiments on dysferlin-deficient muscle fibers subjected to membrane stress.
• In vivo studies using diltiazem treatment in dysferlin-deficient mice subjected to eccentric contraction.

Main Results:

• Dysferlin is enriched in the t-tubule membrane.
• Dysferlin deficiency leads to t-tubule disruption under stress, which is mitigated by reduced external Ca2+ or diltiazem.
• Diltiazem treatment in mice reduced t-tubule damage, inflammation, and necrosis, improving functional recovery.

Conclusions:

• Dysferlin plays a key role in stabilizing t-tubule Ca2+ signaling during membrane stress.
• Targeting L-type Ca2+ channels with diltiazem shows therapeutic promise for dysferlinopathies.
• This finding opens new avenues for treating limb girdle muscular dystrophy 2B and Miyoshi myopathy.